Searchable abstracts of presentations at key conferences in endocrinology

ea0090p218 | Thyroid | ECE2023

Sonographic pattern and risk factors and malignancy in indeterminate thyroid nodules

Riestra Maria , Dieguez Felechosa Marta , Gandara Gutierrez Carmen , Gonzalvo Rodriguez Pablo , Rodriguez Villar Diana , Mendez Lopez Lorena , Fernandez Morais Raquel , Sanchez Canteli Mario , Valdes Gallego Nuria

Introduction: Fine-needle biopsy with cytologic evaluation remains the diagnostic test of choice to distinguish benign from malignant thyroid nodules, but fails to classify thyroid nodules in 15% to 30% of cases (indeterminate thyroid nodules-ITN). ‘Rule out’ molecular testing improves the diagnostic accuracy, with high sensitivity and negative predictive value, ranging from 86 to 96%. However, these tests are not widely available, and notably increase costs. <p ...

ea0041ep804 | Obesity | ECE2016

Medium-term evolution of ghrelin levels according to three types of bariatric surgeries and its relation with HDL and insulin resistance

Santiago-Fernandez Concepcion , Garcia-Serrano Sara , Tome Monica , Valdes Sergio , Ocana-Wilhelmi Luis , Rodriguez-Canete Alberto , Tinahones Francisco J. , Garcia-Fuentes Eduardo , Garrido-Sanchez Lourdes

Introduction: Ghrelin is a gastrointestinal peptide involved in the regulation of body weight and energy balance. However, its behavior after bariatric surgery and its relationship with other biochemical variables is still under discussion. We aim to undertake a simultaneous evaluation of the changes in ghrelin levels after three types of bariatric surgery and its relationship with different variables.Design: The study included 21 non-obese and 103 morbi...

ea0037ep1002 | Thyroid (non-cancer) | ECE2015

Prevalence of thyroid dysfunction in Spain: diabetes study

Valdes Sergio , Maldonado-Araque Cristina , Tapia Maria Jose , Lago Ana , Perez-Valero Vidal , Goday Albert , Castano Luis , Delgado Edelmiro , Vendrell Joan , Rojo-Martinez Gemma , Soriguer Federico

Introduction: Thyroid dysfunction is a common health problem. Its prevalence may vary in different populations, and in Spain, it has not been sufficiently studied. The aim of this study was to evaluate the prevalence of thyroid dysfunction (clinical and subclinical) in our country.Materials and methods: The diabetes study is a national, cross-sectional, population-based survey. Target population: the entire Spanish population >18 years. Sample: >...

ea0070aep889 | Thyroid | ECE2020

Iodine deficiency and mortality in spanish adults. [email protected] study

Valdes Sergio , Colomo Natalia , Maldonado-Araque Cristina , García-Fuentes Eduardo , Calle-Pascual Alfonso , Castaño Luis , Delgado Elias , Franch-Nadal Josep , Soriguer Federico , Rojo-Martinez Gemma

Objective: To study the association between the state of iodine nutrition, and the risk of total and cause mortality in a representative sample of the Spanish adult population.Design: Longitudinal observational study to estimate mortality risk according to urinary iodine (UI) concentrations using a sample of 4370 subjects >18 years representative of the Spanish adult population participating in the national study [email protected] (2008–2010). We used ...

ea0029p688 | Diabetes | ICEECE2012

Insulin protocol for hospital management of diabetes: a retrospective evaluation one year after the implementation

Garcia Torres F. , Valdes S. , Gonzalez-Molero I. , Gonzalo Marin M. , Rubio I. , Garcia Arnes J. , Munoz A. , Olveira G. , Ruiz de Adana M. , Soriguer F.

Introduction: Protocols for identifing and managing hyperglycemia and diabetes in hospital are necessary. Glycemic goals in non critical inpatients are:140 mg/ml(preprandial) and 180(posprandial),oral antidiabetic drug(OADs) withdrawn, avoid hypoglycemias, basal/bolus insulin (nor sliding scale) and request glycosylated haemoglobin.Aims: To evaluate the implementation of a protocol for management of diabetes(PHD) during the years 2009 and 2010 in our Hos...

ea0029p1270 | Obesity | ICEECE2012

Factors determining weight gain in adults and relation with glucose tolerance

Soriguer F. , Rojo-Martinez G. , Valdes S. , Tapias M. , Botas P. , Delgado E. , Esteva I. , Ruiz de Adana M. , Diaz-Cadorniga F. , Garcia-Fuentes E.

Objective: Modifications in lifestyle and diet are major contributors for the high prevalence of obesity. Very few longitudinal studies have evaluated the changes in body weight over time. Dynamic changes in body weight are also an important indicator of risk for type 2 diabetes. The aim of this study is to assess factors associated with weight gain in a population of Spanish adults.Methods: The study was undertaken in two population-based cohorts of Spa...

ea0026p336 | Obesity | ECE2011

Therapy with exenatide in obese and morbidly obese type 2 diabetic patients: comparative analysis

Dieguez Felechosa M , Tuson Rovira C , Sanchez Ragnarsson C , Casal Alvarez F , Valdes Gallego N , Manjon Miguelez L , Prieto Santiago J

Aim: To compare the effectiveness and tolerability of Exenatide twice daily treatment of obese and morbidly obese type 2 diabetic (T2D) patients.Material and methods: To analyze data of obese and severe obese T2D patients initiated on Exenatide in our Endocrine clinics who complete one year of treatment. We separate patients in two groups: group A (BMI<40 kg/m2) and group B (BMI≥40 kg/m2). We did not include any modificati...

ea0026p666 | Diabetes therapy | ECE2011

Experience with the use of a real time continuous glucose monitoring system during the simultaneous pancreas kidney transplant in patients with diabetes

Gonzalez-Molero I , Dominguez-Lopez M , Ruiz de Adana M S , Gonzalez-Romero S , Gonzalo-Marin M , Valdes S , Olveira G , Soriguer F

Introduction: Simultaneous pancreas kidney transplant (SPK) is a prime line treatment option in patients with type 1 diabetes and chronic kidney failure. The glucose control during perioperatory period can be a prognostic factor for transplant. Actually, the utility of the continuous glucose monitoring is not well defined. Our objective was to study the utility of a continuous glucose monitoring system during the simultaneous pancreas kidney transplant.M...

ea0026p679 | Diabetes therapy | ECE2011

Twelve months exenatide treament in type 2 diabetes and severe obesity

Felechosa M Dieguez , Rovira C Tuson , Ragnarsson C Sanchez , Alemany E Suarez-LLedo , Garcia L Cacho , Gallego N Valdes , Santiago J Prieto

Aim: To assess the effectiveness, safety and tolerability of Exenatide twice daily treatment of type 2 diabetes and obesity.Material and methods: Data analysis of obese type 2 diabetic patients initiated on Exenatide therapy in our Endocrine clinics who complete 1 year of treatment.Results: We included 42 patients, 30 women (71.4%) and 12 men (28.6%), mean (±S.D.) age 57±10 and 9±7 years diabetes evolu...

ea0041ep807 | Obesity | ECE2016

Changes in SCD1 promoter DNA methylation after bariatric surgery in morbid obese patients are associated with free fatty acids levels

Morcillo Sonsoles , Martin-Nunez Gracia Ma , Garcia-Serrano Sara , Gutierrez-Repiso Carolina , Rodriguez-Pacheco Francisca , Ho-Plagaro Ailec , Alaminos-Castillo Miguel A , Valdes Sergio , Gonzalo Motserrat , Moreno-Ruiz Francisco J. , Montiel-Casado Custodia , Rodriguez-Canete Alberto , Garcia-Fuentes Eduardo

Introduction: Epigenetic is acquiring great importance in complex diseases, providing mechanisms whereby environmental factors can influence complex diseases such as obesity and type 2 diabetes. Experimental animal and human studies have revealed the association between SCD1 and obesity and insulin resistance. The aim of this study was to evaluate whether metabolic changes after intervention are associated with DNA methylation pattern and if these changes are related to weigh ...